Sun Pharma is all set to enter the lucrative oral contraceptive market in the US, but the going won’t be easy with the entrenched players like Teva and Watson dominating the market. CNBC-TV18’s Archana Shukla reports Sun will even have to take on its Indian peers like Glenmark and Lupin, who have an early mover advantage.
first published: Oct 28, 2011 09:54 pm
A collection of the most-viewed Moneycontrol videos.
LIVE | US Navy seizes Iranian ship; talks uncertain; Nifty 200 DMA key, bank earnings focus now!
Iran Rejects US Talks Again, Strait Of Hormuz Tensions Rise As Oil Route Risks Grow
PM Modi Targets Congress After Women Reservation Bill Defeat, Vows To Remove Obstacles | FULL SPEECH
Trump Claims Iran Will Never Shut Hormuz Again, Big Statement Raises Global Questions
